![Chris Boshoff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chris Boshoff
President chez
SEAGEN INC.
Fortune : 4 M $ au 31/05/2026
Profil
Chris Boshoff currently works at Pfizer Inc., as President-R&D & Chief Scientific Officer from 2025, Seagen, Inc., as President from 2023, and Pfizer (La Jolla), as Vice President-Translational Oncology.
Dr. Boshoff also formerly worked at Advanced Oncotherapy Plc, as Non-Executive Director in 2013 and UCL Cancer Institute Research Trust, as Founding Director.
Dr. Boshoff received his doctorate degree from Institute of Cancer Research Royal Marsden Hospital.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PFIZER INC. 0 % | 03/03/2026 | 162 088 ( 0 % ) | 4 M $ | 31/05/2026 |
Dernières actualités sur Chris Boshoff
Postes actifs de Chris Boshoff
| Sociétés | Poste | Début |
|---|---|---|
| PFIZER INC. | Directeur Technique/Scientifique/R&D | 01/01/2025 |
| SEAGEN INC. | President | 14/12/2023 |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Provides research services | Corporate Officer/Principal | - |
Anciens postes connus de Chris Boshoff
| Sociétés | Poste | Fin |
|---|---|---|
| ADVANCED ONCOTHERAPY PLC | Directeur/Membre du Conseil | 25/10/2013 |
UCL Cancer Institute Research Trust | Directeur/Membre du Conseil | - |
Formation de Chris Boshoff
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Advanced Oncotherapy Plc
 Advanced Oncotherapy Plc Medical SpecialtiesHealth Technology Develops and provides advanced cancer treatments | Health Technology |
Pfizer (La Jolla)
Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Provides research services | Commercial Services |
UCL Cancer Institute Research Trust | |
Institute of Cancer Research Royal Marsden Hospital
 Institute of Cancer Research Royal Marsden Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
